alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0001029815
<NAME> MEDFORD CLINIC, P.C.
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                               1
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   336
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                     336
<CURRENT-LIABILITIES>                              335
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                       336
<SALES>                                              0
<TOTAL-REVENUES>                                10,746
<CGS>                                                0
<TOTAL-COSTS>                                   10,412
<OTHER-EXPENSES>                                   289
<LOSS-PROVISION>                                   359
<INTEREST-EXPENSE>                                  98
<INCOME-PRETAX>                                   (46)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (46)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (46)
<EPS-PRIMARY>                                 (807.02)
<EPS-DILUTED>                                 (807.02)
        

</TABLE>
# C_2014448EN.01000301.xml

| 15.12.2014 | EN | Official Journal of the European Union | C 448/3 |
| --- | --- | --- | --- |

15.12.2014

EN

Official Journal of the European Union

C 448/3

---

Request for a preliminary ruling from the Amtsgericht Rüsselsheim (Germany) lodged on 29 August 2014 — Dagmar Wedel, Rudi Wedel v Condor Flugdienst GmbH

(Case C-412/14)

(2014/C 448/03)

Language of the case: German

Referring court

Referring court

Amtsgericht Rüsselsheim

Parties to the main proceedings

Parties to the main proceedings

Applicants: Dagmar Wedel, Rudi Wedel

Applicants:

Defendant: Condor Flugdienst GmbH

Defendant:

Questions referred

Questions referred

| 1. | Must the extraordinary circumstance within the meaning of Article 5(3) of Regulation No 261/2004 (1) relate directly to the booked flight? |
| --- | --- |

1.

Must the extraordinary circumstance within the meaning of Article 5(3) of Regulation No 261/2004 (1) relate directly to the booked flight?

1

| 2. | If the first question is to be answered in the negative, how many earlier flights involving the aircraft to be used for the scheduled flight are relevant to the existence of an extraordinary circumstance? Is there a time-limit to the consideration of extraordinary circumstances which occur during earlier flights? If so, how is that time-limit to be calculated? |
| --- | --- |

2.

If the first question is to be answered in the negative, how many earlier flights involving the aircraft to be used for the scheduled flight are relevant to the existence of an extraordinary circumstance? Is there a time-limit to the consideration of extraordinary circumstances which occur during earlier flights? If so, how is that time-limit to be calculated?

| 3. | If extraordinary circumstances which occur during earlier flights are also relevant to a later flight, must the reasonable measures to be taken by the operating air carrier, in accordance with Article 5(3) of the regulation, relate only to preventing the extraordinary circumstance or also to avoiding a long delay? |
| --- | --- |

3.

If extraordinary circumstances which occur during earlier flights are also relevant to a later flight, must the reasonable measures to be taken by the operating air carrier, in accordance with Article 5(3) of the regulation, relate only to preventing the extraordinary circumstance or also to avoiding a long delay?

---

(1)  Regulation (EC) No 261/2004 of the European Parliament and of the Council of 11 February 2004 establishing common rules on compensation and assistance to passengers in the event of denied boarding and of cancellation or long delay of flights, and repealing Regulation (EEC) No 295/91 (OJ 2004 L 46, p. 1).

1

---
# Fourth Court of Appeals

San Antonio, Texas

October 18, 2022

No. 04

- 22

- 00647

- CV

IN RE Denise Marie RAMOS

Original Mandamus Proceeding 1

ORDER

Sitting: Luz Elena D. Chapa , Justice

Beth Watkins , Justice

Lori I. Valenzuela , Justice

On September 30

, 2022

, relator filed a petition for writ of mandamus. Relator represented

in her petition that copies of the relevant summary judgment orders 2 would be included in her

appendix. Rela tor’s appendix does not contain the relevant summary judgment orders. We

ORDER relator to file a supplemental appendix containing the relevant summary judgment

orders on or before October 24, 2022

.

This court believes a serious question concerning the mandamus relief sought requires

further consideration. See T EX

. R. A PP

. P. 52.8(b). R espondent and r eal part y in interest may file

a response to the petition in this court on or befor e fifte en da ys from the date the supplemental

appendix is filed. Any such response must conform to Texas Rule of Appellate Procedure 52.4.

It is so ORDERED on October 18, 2022

.

PER CURIAM

ATTESTED TO:

_________________________

MICHAEL A. CRUZ

, CLERK OF COURT

1 This proceeding arises out of Cause No. 2018

- CI

- 21009 , styled In the Matter of the Marriage of Denise Marie

Ramos and Reynaldo Esparza Jr , pending in the 166th Judicial District Court

, Bexar County, Texas, the Honorable

Laura Salinas presiding.

2 The relevant summary judgment orders include rulings on relator’s claims for an informal marriage, breach of

contract, real estate fraud, and quantum meruit.
§ 522.2063 Pyrilamine. ( a ) *Specifications.* Each milliliter of solution contains 20 milligrams (mg) of pyrilamine maleate.
( b ) *Sponsors.* See sponsor numbers in § 510.600(c) of this chapter for uses in paragraph (c) of this section. ( 1 ) No. 000061 for use as in paragraph (c)(1)(i), (2), and (3) of this section.
( 2 ) No. 061133 for use as in paragraph (c)(1)(ii), (2), and (3) of this section.
( c ) *Conditions of use* — ( 1 ) *Amount.* ( i ) Horses, 40 to 60 mg per 100 pounds (lbs) body weight; foals, 20 mg/100 lbs body weight. Administer by intramuscular, subcutaneous, or intravenous injection. Dosage may be repeated every 6 to 12 hours whenever necessary.
( ii ) Horses, 40 to 60 mg/100 lbs body weight; foals, 20 mg/100 lbs body weight. Administer by slow intravenous injection. Dosage may be repeated every 6 to 12 hours if necessary.
( 2 ) *Indications for use.* It is intended for treating horses in conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 16195, Mar. 25, 2014, as amended at 84 FR 8974, Mar. 13, 2019]
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUN-26-2000
<PERIOD-END>                               SEP-24-2000
<CASH>                                             306
<SECURITIES>                                         0
<RECEIVABLES>                                   89,928
<ALLOWANCES>                                     7,186
<INVENTORY>                                      2,775
<CURRENT-ASSETS>                                61,115
<PP&E>                                          13,642
<DEPRECIATION>                                   5,524
<TOTAL-ASSETS>                                 157,395
<CURRENT-LIABILITIES>                           14,752
<BONDS>                                         84,357
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      25,868
<TOTAL-LIABILITY-AND-EQUITY>                   157,395
<SALES>                                         24,157
<TOTAL-REVENUES>                                 3,168
<CGS>                                           10,815
<TOTAL-COSTS>                                   25,704
<OTHER-EXPENSES>                                   535
<LOSS-PROVISION>                                 3,044
<INTEREST-EXPENSE>                               4,291
<INCOME-PRETAX>                                (3,205)
<INCOME-TAX>                                     (952)
<INCOME-CONTINUING>                            (2,253)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,253)
<EPS-BASIC>                                          0<F1>
<EPS-DILUTED>                                        0<F1>
<FN>
<F1>THE COMPANY DOES NOT REPORT EPS AS THERE IS NO PUBLIC MARKET FOR ITS EQUITY.
THE COMPANY DOES HAVE PUBLICLY OWNED DEBT.
</FN>


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Export-Import Bank of the United States

# SUMMARY:

The Advisory Committee was established by Public Law 98-181, November 30, 1983, to advise the Export-Import Bank on its programs and to provide comments for inclusion in the reports of the Export-Import Bank of the United States to Congress.

# Time and Place:

 Friday, March 12, 2010 beginning at 2:30 p.m. The meeting will be held in the Palladian Room at the Onmi Shoreham Hotel, 2500 Calvert Street, NW., Washington, DC 20008.

*Agenda:*                         Agenda items include a briefing on the status of the 2010 Advisory Committee's Subcommittees and the challenges for 2010.                    

*Public Participation:*                         The meeting will be open to public participation, and the last 10 minutes will be set aside for oral questions or comments. Members of the public may also file written statement(s) before or after the meeting. If any person wishes auxiliary aids (such as a sign language interpreter) or other special accommodations, please contact, prior to March 3, 2010, Susan Houser, Room 1273, 811 Vermont Avenue, NW., Washington, DC 20571,                         *Voice:*                         (202) 565-3232 or TDD (202) 565-3377.                    

# FOR FURTHER INFORMATION CONTACT:

For further information, contact Susan Houser, Room 1273, 811 Vermont Ave., NW., Washington, DC 20571, (202) 565-3232.

Jonathan Cordone,

Senior Vice President and General Counsel.

[FR Doc. 2010-4208 Filed 3-1-10; 8:45 am]

BILLING CODE 6690-01-M
§ 524.1193 Ivermectin topical solution. ( a ) *Specifications.* Each milliliter (mL) of solution contains 5 milligrams of ivermectin.
( b ) *Sponsors.* See Nos. 000010, 016592, 055529, 058829, and 061133 in § 510.600(c) of this chapter for use as in paragraph (d) of this section.
( c ) *Related tolerances.* See § 556.344 of this chapter.
( d ) *Conditions of use in cattle* — ( 1 ) *Amount.* One mL per 22 pounds (0.5 milligram per kilogram) of body weight applied topically to the back of the animal.
( 2 ) *Indications for use.* It is used for the treatment and control of: Gastrointestinal roundworms (adults and fourth-stage larvae) *Ostertagia ostertagi* (including inhibited stage), *Haemonchus placei, Trichostrongylus axei,* *T. colubriformis, Cooperia oncophora,* *C. punctata, C. surnabada,* *Oesophagostomum radiatum* (adults); *Strongyloides papillosus, Trichuris* spp.; lungworms (adults and fourth-stage larvae) *Dictyocaulus viviparus;* cattle grubs (parasitic stages) *Hypoderma bovis, H. lineatum;* mites *Sarcoptes scabiei* var. *bovis;* lice *Linognathus vituli, Haematopinus eurysternus,* *Damalinia bovis, Solenoptes capillatus;* and horn flies *Haematobia irritans.* It controls infections and prevents reinfection with *O. radiatum* and *D. viviparus* for 28 days after treatment, *C. punctata* and *T. axei* for 21 days after treatment, *O. ostertagi, H. placei,* *C. oncophora,* and *C. surnabada* for 14 days after treatment, and *D. bovis* for 56 days after treatment.
( 3 ) *Limitations.* Do not treat cattle within 48 days of slaughter. Do not use on female dairy cattle of breeding age or on calves to be processed for veal. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
[55 FR 50551, Dec. 7, 1990, as amended at 62 FR 38908, July 21, 1997; 62 FR 63271, Nov. 28, 1997; 63 FR 44385, Aug. 19, 1998; 66 FR 13236, Mar. 5, 2001; 66 FR 63165, Dec. 5, 2001; 68 FR 3817, Jan. 27, 2003; 68 FR 4713, Jan. 30, 2003; 69 FR 501, Jan. 6, 2004; 69 FR 62181, Oct. 25, 2004; 71 FR 13542, Mar. 16, 2006; 72 FR 6464, Feb. 12, 2007; 74 FR 36112, July 22, 2009; 75 FR 26648, May 12, 2010; 76 FR 81807, Dec. 29, 2011; 78 FR 17597, Mar. 22, 2013; 78 FR 63872, Oct. 25, 2013; 81 FR 25328, Apr. 28, 2016; 83 FR 13635, Mar. 30, 2018; 84 FR 8974, Mar. 13, 2019; 84 FR 39184, Aug. 9, 2019; 86 FR 13185, Mar. 8, 2021; 88 FR 84701, Dec. 6, 2023; 89 FR 42360, May 15, 2024]
**EXHIBIT
      32.1**




**CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**




In
      connection with the Quarterly Report of Central Wireless, Inc. (the “Company”)
      on Form 10-QSB for the quarter ended March 31, 2006 as filed with the Securities
      and Exchange Commission on the date hereof (the “Report”), the undersigned, in
      the capacities and on the dates indicated below, hereby certifies pursuant
      to 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that to his knowledge:




1.
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




2.
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operation of the Company.


Date:
                January 23, 2007
            By:
            /s/ *Kenneth
              W. Brand*Kenneth
                W. Brand
              Chief
                Executive Officer




A
      signed
      original of this written statement required by Section 906, or other document
      authentications, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906, has been provided to Central Wireless, Inc. and will be retained
      by Central Wireless, Inc. and furnished to the Securities and Exchange
      Commission or its staff upon request.
IN THE SUPREME COURT OF THE STATE OF NEVADA

SUE WAGNER, AN INDIVIDUAL, Appellant, vs. BARBARA K. CEGAVSKE, IN HER OFFICIAL CAPACITYAS NEVADA SECRETARY; AND PROTECT OUR GIRLS, A POLITICAL ACTION COMMITTEE, 

# Respondents. No. 85038 

# FILE OCT 25 2022

HA. EMOWN EME COURT EPUTYCLERK ORDER DISMISSING APPEAL AND VACATING ORAL ARGUMENT

Pursuant to the stipulation ofthe parties, and cause appearing, this appealis dismissed. The parties shallbear their own costs and attorney fees. NRAP 42(b). Further, the oral argument in this matter currently scheduled for November 7, 2022, at 1:30 p.m. is vacated. 

# 1 :2141)L Parraguirre

cc: Wolf, Rifkin, Shapiro, Schulman & Rabkin, LLP/Las Vegas Wolf, Rifkin, Shapiro, Schulman & Rabkin, LLP/Reno Attorney General/Carson City Attorney General/Las Vegas Hutchison & Steffen, LLC/Reno , C.J.

SUPREME COURT

OF NEVADA
800 Independence Ave.

Washington, DC 20591

February 4, 2014

Mr. Robert E. Cohn

Columbia Square

Hogan Lovells US LLP

555 Thirteenth Street, NW.

Washington, DC 20004

Dear Mr. Cohn:

This is in response to your March 21, 2013 letter (public docket No. FAA-2013-0294), 

cosigned by Mr. Patrick R. Rizzi, petitioning the Federal Aviation Administration (FAA) on 

behalf of Republic Airline Inc. (“Republic”) for an exemption from §§ 121.500-121.505 of 

Title 14, Code of Federal Regulations (14 CFR). That exemption, if granted, would have 

permitted Republic to operate supplemental operations in accordance with the flight, duty, 

and rest time requirements for domestic operations instead of those applicable to supplemental 

operations.

On January 4, 2012, the FAA issued the “Flightcrew Member Duty and Rest Requirements” 

final rule (77 FR 330). This rule, effective January 4, 2014, created 14 CFR part 117, which

replaces existing flight, duty, and rest time regulations for part 121 passenger operations. 

Part 117 removes distinctions between domestic, supplemental, and flag passenger operations 

in regard to flight, duty, and rest time requirements. 

Since the relief requested is covered under the new rule, we will take no further action on 

your petition. 

Sincerely,

/s/

Leslie H. Smith 

Manager, Air Transportation Division
2

Project No.: AFS-13-333-E

Project Officer: _______________

ARM-101:KJones:2/4/2014:Doc#37950

ARM-1/100/104:Program Office AFS-200

MR ROBERT E COHN

COLUMBIA SQUARE

HOGAN LOVELLS US LLP

555 THIRTEENTH STREET NW

WASHINGTON DC 20004
### Notes **from Meeting with HDMA** 

**Attended by:** HDMA Staff: Allison Tuszynski and Anita Ducca Other Staff: Tish Pahl, OFW Law

Bob Fensterheim, RegNet Environmental Services EPA Staff : Mary Jackson and Kristin Fitzgerald **Date:** January 7, 2014 EPA met with representatives from the Healthcare Distribution Management Association (HDMA), the ir outside counsel and consultant . They discussed their members’ roles in the distribution and reverse distribution of pharmaceuticals. They also discussed the rece ntly enacted law, the Drug Quality and Security Act (DQSA). They indicated that in 2010, approximately 2% of pharmaceuticals are returned to reverse distributors.
I 

118TH CONGRESS 

2D SESSION H. R. 7599 

To amend title XVIII of the Social Security Act to expand the eligibility 

for designation as a rural emergency hospital under the Medicare program. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 8, 2024 

Mr. LATURNER introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To amend title XVIII of the Social Security Act to expand 

the eligibility for designation as a rural emergency hospital under the Medicare program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Rural Emergency Hos5 pital Adjustment Act’’. 

6 SEC. 2. EXPANDING THE ELIGIBILITY FOR DESIGNATION AS 

7 A MEDICARE RURAL EMERGENCY HOSPITAL. 

8 Section 1861(kkk)(3) of the Social Security Act (42 

9 U.S.C. 1395x(kkk)(3)) is amended, in the matter pre10 ceding subparagraph (A), by striking ‘‘as of’’ and insertVerDate Sep 11 2014 16:07 Mar 17, 2024 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H7599.IH H7599

ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7599 IH

1 ing ‘‘at any point during the period beginning on January 

2 1, 2015, and ending on’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
# C_2014102EN.01001501.xml

| 7.4.2014 | EN | Official Journal of the European Union | C 102/15 |
| --- | --- | --- | --- |

7.4.2014

EN

Official Journal of the European Union

C 102/15

---

Request for a preliminary ruling from the Hof van Beroep te Gent (Belgium) lodged on 16 January 2014 — Property Development Company NV v Belgische Staat

(Case C-16/14)

2014/C 102/20

Language of the case: Dutch

Referring court

Referring court

Hof van Beroep te Gent

Parties to the main proceedings

Parties to the main proceedings

Applicant: Property Development Company NV

Applicant:

Defendant: Belgische Staat

Defendant:

Question referred

Question referred

Is interest on borrowed capital which, according to Article 35(4) of the Fourth Council Directive 78/660/EEC (1) of 25 July 1978, may be included in the production costs to the extent that it relates to the period of production, part of the taxable amount of an application within the meaning of Article 5(6) of Sixth Council Directive 77/388/EEC (2) of 17 May 1977, that is to say, part of the ‘cost price’ within the meaning of Article 11A(1) of the Sixth Directive and/or the incidental expenses within the meaning of Article 11A(2) of the Sixth Directive?

1

2

---

(1)  Fourth Council Directive 78/660/EEC of 25 July 1978 based on Article 54 (3)(g) of the Treaty on the annual accounts of certain types of companies (OJ 1978 L 222, p. 11).

1

(2)  Sixth Council Directive 77/388/EEC of 17 May 1977 on the harmonization of the laws of the Member States relating to turnover taxes — Common system of value added tax: uniform basis of assessment (OJ 1977 L 145, p. 1).

2

---
§ 582.1792 Sodium sesquicarbonate. ( a ) *Product.* Sodium sesquicarbonate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
§ 528.1092 opAFP-GHc2 recombinant deoxyribonucleic acid construct. ( a ) *Specifications.* A single copy of the α-form of the *opAFP-GHc2* recombinant deoxyribonucleic acid (rDNA) construct at the α-locus in the EO-1 α lineage of triploid, hemizygous, all-female Atlantic salmon (*Salmo salar*).
( b ) *Sponsor.* See No. 086053 in § 510.600 of this chapter.
( c ) *Indications for use.* Significantly more of these Atlantic salmon grow to at least 100 grams within 2,700 Celsius degree-days than their comparators.
( d ) *Limitations.* These Atlantic salmon are produced as eyed-eggs and grown-out only in physically-contained, freshwater culture facilities specified in an FDA-approved application.
[80 FR 73104, Nov. 24, 2015]